Termination of clinical trials: The beta-blocker heart attack trial and the hypertension detection and follow-up program experience

Canner, 1977, Monitoring treatment differences in long-term clinical trials, Biometrics, 33, 603, 10.2307/2529458 Dupont, 1983, Sequential stopping rules and sequentially adjusted p values: Does one require the other, Controlled Clin Trials, 4, 3, 10.1016/S0197-2456(83)80003-8 Halperin, 1982, An aid to data monitoring in long-term clinical trials, Controlled Clin Trials, 3, 311, 10.1016/0197-2456(82)90022-8 Halperin, 1974, Early decision in a censored Wilcoxon two-sample test for accumulating survival data, J Am Statist Assoc, 69, 414, 10.2307/2285671 Canner, 1983, Monitoring of the data, Controlled Clin Trials, 4, 467, 10.1016/0197-2456(83)90029-6 Friedman, 1982, Fundamentals of Clinical Trials, 195 Klimt, 1979, Terminating a long-term clinical trial, Clin Pharmacol Ther, 25, 641, 10.1002/cpt1979255part2641 Bell, 1983, Early Termination in a Clinical Trial Krol, 1983, Closing down the study, Controlled Clin Trials, 4, 505, 10.1016/0197-2456(83)90031-4 1979, Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension, JAMA, 242, 2562, 10.1001/jama.1979.03300230018021 1982, A randomized trial of propranolol in patients with acute myocardial infarction: I. Mortality results, JAMA, 247, 1707, 10.1001/jama.1982.03320370021023 1981, The β-Blocker Heart Attack Trial Preliminary Report, JAMA, 246, 2073, 10.1001/jama.1981.03320180063037 Overton, 1981, AMIS Close-Out Schneider, 1984